MetLife (MET) Tops Q1 EPS by 3c
Get Alerts MET Hot Sheet
Price: $97.62 -1.62%
Revenue Growth %: +15.8%
Financial Fact:
Net derivative gains (losses): -1.05B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +15.8%
Financial Fact:
Net derivative gains (losses): -1.05B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
MetLife (NYSE: MET) reported Q1 EPS of $1.44, $0.03 better than the analyst estimate of $1.41. Revenue for the quarter came in at $17.03 billion versus the consensus estimate of $17.53 billion.
Premiums, fees & other revenues* were $12.1 billion, essentially unchanged from the first quarter of 2014 (up 4 percent on a constant currency basis).
Book value, excluding AOCI other than FCTA*, was $50.45 per share, up 6 percent from $47.70 per share at March 31, 2014.
For earnings history and earnings-related data on MetLife (MET) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Bernstein SocGen Group Reiterates Outperform Rating on Zydus Lifesciences (ZYDUSLIF:IN)
- BlackRock’s Rosenberg says inflation data key after jobs beat
Create E-mail Alert Related Categories
Earnings, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share